Title : Pharmacokinetic Characteristics of Siponimod in Healthy Volunteers and Patients With Multiple Sclerosis: Analyses of Published Clinical Trials.

Pub. Date : 2022

PMID : 35620290






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The dosage regimen, body mass index, CYP2C9 genetic polymorphism and fluconazole combination may had influences on siponimod pharmacokinetics. siponimod cytochrome P450 family 2 subfamily C member 9 Homo sapiens